Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Advances in Phytosome Technology for Targeted Cancer Therapy

View through CrossRef
Background: Nowadays, medicinal herbs and their phytochemicals have emerged as a great therapeutic option for many disorders. However, poor bioavailability and selectivity might limit their clinical application. Among all approaches, phyto-phospholipid complexes (named phytosomes) have appeared to be a great method to overcome the problems. With the new developments in drug delivery technologies, anticancer drugs ranging from hydrophilic macromolecules to lipophilic drugs can be administered via phytosomes to treat cancer. Objective: In the present review, various drugs targeted by phytosomes to treat varied forms of cancer, like breast cancer, pancreatic cancer, lung cancer, colon cancer, prostate cancer, etc, are discussed. Methods: In this review, recent literature covering phytosomes to treat various forms of cancer, patent applications, and clinical trials involving phytosomes employed to cure mainly cancer are covered. Results: Phytosomes have proved their potential to cure cancer. They increase the bioavailability of the drug by site-specific drug delivery and can reduce the side effects/- toxicity associated with anticancer drugs and also sustain the release of drugs. Conclusion: The potential of phytosomes to carry the drug may unclutter novel ways for therapeutic intercessions in various tumors.
Title: Advances in Phytosome Technology for Targeted Cancer Therapy
Description:
Background: Nowadays, medicinal herbs and their phytochemicals have emerged as a great therapeutic option for many disorders.
However, poor bioavailability and selectivity might limit their clinical application.
Among all approaches, phyto-phospholipid complexes (named phytosomes) have appeared to be a great method to overcome the problems.
With the new developments in drug delivery technologies, anticancer drugs ranging from hydrophilic macromolecules to lipophilic drugs can be administered via phytosomes to treat cancer.
Objective: In the present review, various drugs targeted by phytosomes to treat varied forms of cancer, like breast cancer, pancreatic cancer, lung cancer, colon cancer, prostate cancer, etc, are discussed.
Methods: In this review, recent literature covering phytosomes to treat various forms of cancer, patent applications, and clinical trials involving phytosomes employed to cure mainly cancer are covered.
Results: Phytosomes have proved their potential to cure cancer.
They increase the bioavailability of the drug by site-specific drug delivery and can reduce the side effects/- toxicity associated with anticancer drugs and also sustain the release of drugs.
Conclusion: The potential of phytosomes to carry the drug may unclutter novel ways for therapeutic intercessions in various tumors.

Related Results

Nghiên cứu bào chế curcumin dạng phytosome và dạng PEG hóa
Nghiên cứu bào chế curcumin dạng phytosome và dạng PEG hóa
Curcumin có nhiều tác dụng dược lý quan trọng nhưng chưa được ứng dụng nhiều trên lâm sàng do sinh khả dụng thấp. Phytosome curcumin và PEG-CUR được nghiên cứu để tăng sinh khả dụn...
DEVELOPMENT AND IN VITRO EVALUATION OF PHYTOSOME OF TERBINAFINE HYDROCHLORIDE FOR ORAL DRUG DELIVERY
DEVELOPMENT AND IN VITRO EVALUATION OF PHYTOSOME OF TERBINAFINE HYDROCHLORIDE FOR ORAL DRUG DELIVERY
Objective: The purpose of this study was to develop and in vitro evaluation phytosome of terbinafine HCL to enhance the bioavailability for oral route. Methods: The novel phytosom...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

Back to Top